Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
16
LINE Quote, Financials, Valuation and Earnings
Last price:
$41.49
Seasonality move
:
--
Day range:
$40.49 - $42.10
52-week range:
$40.49 - $89.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.71x
P/B ratio:
1.09x
Volume:
1.2M
Avg. volume:
933.5K
1-year change:
--
Market cap:
$9.3B
Revenue:
$5.3B
EPS (TTM):
-$3.07
Analysts' Opinion
-
Consensus RatingLineage has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $54.67, Lineage has an estimated upside of 33.82% from its current price of $40.85.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $42.00 representing -2.82% downside risk from its current price of $40.85.
Fair Value
-
According to the consensus of 14 analysts, Lineage has 33.82% upside to fair value with a price target of $54.67 per share.
LINE vs. S&P 500
-
Over the past 5 trading days, Lineage has underperformed the S&P 500 by -4.75% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Lineage does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lineage revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Lineage reported revenues of $1.3B.
Earnings Growth
-
Lineage has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Lineage reported earnings per share of $0.01.
Enterprise value:
15.4B
EV / Invested capital:
--
Price / LTM sales:
1.71x
EV / EBIT:
--
EV / Revenue:
2.90x
PEG ratio (5yr expected):
-0.03x
EV / Free cash flow:
366.38x
Price / Operating cash flow:
215.89x
Enterprise value / EBITDA:
28.87x
Gross Profit (TTM):
$1.7B
Return On Assets:
-3.31%
Net Income Margin (TTM):
-11.77%
Return On Equity:
-6.96%
Return On Invested Capital:
-4.19%
Operating Margin:
3.87%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | $5.3B | $5.3B | $1.3B | $1.3B | |
| Gross Profit | -- | $1.8B | $1.7B | $444M | $416M | |
| Operating Income | -- | $452M | $288M | $109M | $50M | |
| EBITDA | -- | $1.2B | $533M | $312M | $298M | |
| Diluted EPS | -- | -$0.63 | -$3.07 | -$0.20 | $0.01 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $1.3B | $1.4B | |
| Total Assets | -- | -- | -- | $18.7B | $18.8B | |
| Current Liabilities | -- | -- | -- | $1.2B | $1.4B | |
| Total Liabilities | -- | -- | -- | $9.1B | $9.1B | |
| Total Equity | -- | -- | -- | $9.6B | $9.6B | |
| Total Debt | -- | -- | -- | $5.2B | $5.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $793.5M | $737M | $105M | $139M | |
| Cash From Investing | -- | -$1B | -$855M | -$202M | -$138M | |
| Cash From Financing | -- | $111.7M | $220M | $121M | $21M | |
| Free Cash Flow | -- | $109.2M | $42M | -$42M | -$12M | |
LINE
Sector
Market Cap
$9.3B
$1B
Price % of 52-Week High
45.47%
84.86%
Dividend Yield
0%
3.17%
Shareholder Yield
-30.21%
4.03%
1-Year Price Total Return
--
--
Beta (5-Year)
--
0.765
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
-41.03%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$42.35
200-day SMA
Sell
Level
$57.98
Bollinger Bands (100)
Sell
Level
43.84 - 57.16
Chaikin Money Flow
Sell
Level
-2.7M
20-day SMA
Sell
Level
$43.55
Relative Strength Index (RSI14)
Sell
Level
32.53
ADX Line
Sell
Level
17
Williams %R
Buy
Level
-93.0769
50-day SMA
Sell
Level
$44.47
MACD (12, 26)
Buy
Level
11.39
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Sell
Level
-2.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.9706)
Sell
CA Score
(Annual)
Level (-1.0541)
Buy
Beneish M-Score
(Annual)
Level (-2.8543)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-0.9254)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lineage Inc is a temperature-controlled warehouse real estate investment trust. It operates an interconnected global temperature-controlled warehouse network, comprising approximately millions of square feet across several warehouses predominantly located in densely populated critical-distribution markets across North America, Asia-Pacific, and Europe. The company's reportable segments are Global Warehousing, which utilizes the company's industrial real estate properties to provide temperature-controlled warehousing services to its customers, and Global Integrated Solutions, which complements Global Warehousing with specialized cold-chain services. Maximum revenue is generated from the Global Warehousing segment. Geographically, the company derives its key revenue from the United States.
Stock Forecast FAQ
In the current month, LINE has received 4 Buy ratings 10 Hold ratings, and 0 Sell ratings. The LINE average analyst price target in the past 3 months is $54.67.
-
Where Will Lineage Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lineage share price will rise to $54.67 per share over the next 12 months.
-
What Do Analysts Say About Lineage?
Analysts are divided on their view about Lineage share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lineage is a Sell and believe this share price will drop from its current level to $42.00.
-
What Is Lineage's Price Target?
The price target for Lineage over the next 1-year time period is forecast to be $54.67 according to 14 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is LINE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lineage is a Hold. 10 of 14 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of LINE?
You can purchase shares of Lineage via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lineage shares.
-
What Is The Lineage Share Price Today?
Lineage was last trading at $41.49 per share. This represents the most recent stock quote for Lineage. Yesterday, Lineage closed at $40.85 per share.
-
How To Buy Lineage Stock Online?
In order to purchase Lineage stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
